Adagene Inc. (ADAG) stock
ADAGNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.48−0.12 (-7.50%)
Close on Nov 17, 2026Market cap $87.66MP/E –Yield –
Adagene total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Adagene's total debt was $5.73M at Jun 30, 2026. For fiscal 2025 it was $6.12M, down 66.4% from the year before. The highest annual figure on record is $27.77M in fiscal 2022.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.12M | -66.4% |
| FY2024 | Dec 31, 2024 | $18.21M | -17.0% |
| FY2023 | Dec 31, 2023 | $21.94M | -21.0% |
| FY2022 | Dec 31, 2022 | $27.77M | +270.7% |
| FY2021 | Dec 31, 2021 | $7.49M | -6.2% |
| FY2020 | Dec 31, 2020 | $7.98M | +212.4% |
| FY2019 | Dec 31, 2019 | $2.56M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $5.73M | -72.1% |
| Q4 FY2025 | Dec 31, 2025 | $6.12M | -72.1% |
| Q2 FY2025 | Jun 30, 2025 | $6.64M | -76.1% |
| Q4 FY2024 | Dec 31, 2024 | $18.21M | +143.1% |
| Q2 FY2024 | Jun 30, 2024 | $20.54M | +157.3% |
| Q4 FY2023 | Dec 31, 2023 | $21.94M | +758.6% |
| Q4 FY2022 | Dec 31, 2022 | $27.77M | – |
| Q4 FY2021 | Dec 31, 2021 | $7.49M | – |
| Q4 FY2020 | Dec 31, 2020 | $7.98M | – |
| Q4 FY2019 | Dec 31, 2019 | $2.56M | – |
See a number that looks wrong?